ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Connect Biopharma Initiates Phase 2 Clinical Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis
July 20, 2020Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating molecules, today announced that the first patient has been dosed in a Phase 2 clinical trial of CBP-201 for the treat -
Connect Biopharma Reports Positive Data from Atopic Dermatitis Study
January 09, 2020Connect Biopharma announced positive topline data from the Phase 1b study of its novel IL-4Rα antibody, CBP-201, in patients with moderate-to-severe atopic dermatitis (AD).
Pharma Sources Insight January 2025
